A detailed history of Mcf Advisors LLC transactions in Rx Sight, Inc. stock. As of the latest transaction made, Mcf Advisors LLC holds 657 shares of RXST stock, worth $29,453. This represents 0.0% of its overall portfolio holdings.

Number of Shares
657
Previous 603 8.96%
Holding current value
$29,453
Previous $36,000 11.11%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$40.78 - $57.04 $2,202 - $3,080
54 Added 8.96%
657 $32,000
Q1 2024

Apr 16, 2024

SELL
$35.51 - $57.92 $6,462 - $10,541
-182 Reduced 23.18%
603 $31,000
Q4 2023

Feb 01, 2024

SELL
$20.91 - $40.9 $2,530 - $4,948
-121 Reduced 13.36%
785 $31,000
Q3 2023

Oct 19, 2023

SELL
$27.05 - $33.37 $2,894 - $3,570
-107 Reduced 10.56%
906 $25,000
Q2 2023

Jul 24, 2023

SELL
$16.37 - $28.9 $818 - $1,445
-50 Reduced 4.7%
1,013 $29,000
Q1 2023

Apr 18, 2023

BUY
$12.58 - $16.68 $3,509 - $4,653
279 Added 35.59%
1,063 $17,000
Q4 2022

Jan 31, 2023

BUY
$9.93 - $14.2 $7,785 - $11,132
784 New
784 $9,000

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $1.24B
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track Mcf Advisors LLC Portfolio

Follow Mcf Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcf Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mcf Advisors LLC with notifications on news.